Literature DB >> 20380869

8,8''-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8''-biapigeninyl in ovariectomized mice.

Jawed A Siddiqui1, Gaurav Swarnkar, Kunal Sharan, Bandana Chakravarti, Gunjan Sharma, Preeti Rawat, Manmeet Kumar, Faheem M Khan, Dominique Pierroz, Rakesh Maurya, Naibedya Chattopadhyay.   

Abstract

8,8''-Biapigeninyl (BA), a condensation product of two apigenin molecules, is found abundantly in the nuts of Cupressus sempervirens. We investigated the effects of BA on murine bone cells in vitro and in ovariectomized (OVx) mice. BA at 10(-10)M and 10(-8)M, inhibited osteoclastogenesis of bone marrow cells (BMCs) and displayed concentration dependence. BA at 10(-8) M and 10(-6) M inhibited differentiation of 3T3-L1 and BMCs to mature adipocytes. BA (10(-10)M) stimulated osteoblast proliferation, differentiation and mineralization. In stimulating osteoblast function, BA was found to be 10(4)-fold more potent than apigenin. The effect of BA in osteoblasts appeared to be mediated via estrogen receptors (ER) as antiestrogen, ICI-182780 abolished BA-stimulated osteoblast differentiation. In OVx mice BA treatment (at 1.0-, 5.0- and 10.0 mg kg(-1) day(-1) doses) given orally for 30 days dose-dependently inhibited mRNA levels of osteoclastic genes including tartrate-resistant acid phosphatase, receptor activator of nuclear factor (RANK), tumor necrosis factor alpha, interleukin-6 and the ratio of RANK ligand/osteoprotegerin ratio in bones compared with OVx mice treated with vehicle. In addition, BA treatment to OVx mice dose-dependently stimulated production of osteoprogenitor cells in the bone marrow and increased mRNA levels of osteogenic genes core binding factor alpha-1, type I collagen and bone morphogenic protein-2 in bones compared with OVx+vehicle group. Microcomputed tomography revealed that BA treatment to OVx mice improved parameters of trabecular and cortical architecture. BA exhibited no uterine estrogenicity. From these data, we conclude that BA exerts osteoprotective effect in OVx mice by multiple beneficial effects on bone cells. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20380869     DOI: 10.1016/j.mce.2010.03.024

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

1.  Chlorpyrifos Exposure Induces Parkinsonian Symptoms and Associated Bone Loss in Adult Swiss Albino Mice.

Authors:  Shaheen Jafri Ali; Govindraj Ellur; Kalpana Patel; Kunal Sharan
Journal:  Neurotox Res       Date:  2019-07-31       Impact factor: 3.911

2.  A naturally occurring naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblasts.

Authors:  Gaurav Swarnkar; Kunal Sharan; Jawed A Siddiqui; Jay Sharan Mishra; Kainat Khan; Mohd Parvez Khan; Varsha Gupta; Preeti Rawat; Rakesh Maurya; Anil K Dwivedi; Sabyasachi Sanyal; Naibedya Chattopadhyay
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone.

Authors:  J A Siddiqui; G Swarnkar; K Sharan; B Chakravarti; A K Gautam; P Rawat; M Kumar; V Gupta; L Manickavasagam; A K Dwivedi; R Maurya; N Chattopadhyay
Journal:  Osteoporos Int       Date:  2011-01-12       Impact factor: 4.507

4.  Treadmill training regulates β-catenin signaling through phosphorylation of GSK-3β in lumbar vertebrae of ovariectomized rats.

Authors:  Shumin Bu; Yu Chen; Shouhui Wang; Fan Zhang; Gang Ji
Journal:  Eur J Appl Physiol       Date:  2012-01-18       Impact factor: 3.078

5.  A novel therapeutic approach with Caviunin-based isoflavonoid that en routes bone marrow cells to bone formation via BMP2/Wnt-β-catenin signaling.

Authors:  P Kushwaha; V Khedgikar; J Gautam; P Dixit; R Chillara; A Verma; R Thakur; D P Mishra; D Singh; R Maurya; N Chattopadhyay; P R Mishra; R Trivedi
Journal:  Cell Death Dis       Date:  2014-09-18       Impact factor: 8.469

6.  Catabolic Effects of Human PTH (1-34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism.

Authors:  Jawed A Siddiqui; Joshua Johnson; Carole Le Henaff; Claudine L Bitel; Joseph A Tamasi; Nicola C Partridge
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

7.  TRPM8 channel inhibitor-encapsulated hydrogel as a tunable surface for bone tissue engineering.

Authors:  Tusar Kanta Acharya; Satish Kumar; Nikhil Tiwari; Arijit Ghosh; Ankit Tiwari; Subhashis Pal; Rakesh Kumar Majhi; Ashutosh Kumar; Rashmita Das; Abhishek Singh; Pradip K Maji; Naibedya Chattopadhyay; Luna Goswami; Chandan Goswami
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

8.  Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling.

Authors:  Jawed A Siddiqui; Carole Le Henaff; Joshua Johnson; Zhiming He; Daniel B Rifkin; Nicola C Partridge
Journal:  Bone       Date:  2020-11-17       Impact factor: 4.398

9.  GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation.

Authors:  Jawed Akhtar Siddiqui; Parthasarathy Seshacharyulu; Sakthivel Muniyan; Ramesh Pothuraju; Parvez Khan; Raghupathy Vengoji; Sanjib Chaudhary; Shailendra Kumar Maurya; Subodh Mukund Lele; Maneesh Jain; Kaustubh Datta; Mohd Wasim Nasser; Surinder Kumar Batra
Journal:  Bone Res       Date:  2022-01-20       Impact factor: 13.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.